The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Evoke PLC
F:C8V
|
GI |
|
S
|
SVS Ventures Ltd
BSE:543745
|
IN |
|
E
|
Ecoplastic Corp
KOSDAQ:038110
|
KR |
|
Mene Inc
XTSX:MENE
|
CA |
|
M
|
Mirae Asset Vision Special Purpose Acquisition 7 Co
KOSDAQ:482680
|
KR |
|
K
|
Kolon Life Science Inc
KOSDAQ:102940
|
KR |
|
Prada SpA
F:PRP0
|
IT |
|
Borosil Ltd
NSE:BOROLTD
|
IN |
|
Empire Company Ltd
TSX:EMP.A
|
CA |
|
Bitcoin Group SE
F:ADE
|
DE |
|
Taskus Inc
F:6VY
|
US |
|
Evoke PLC
LSE:EVOK
|
GI |
|
K
|
Kinder Morgan Inc
XMUN:2KD
|
US |
|
Roots Corp
TSX:ROOT
|
CA |
|
C
|
Cohen & Steers Inc
F:FG9
|
US |
|
Teleperformance SE
F:RCF0
|
FR |
|
Applovin Corp
F:6RV
|
US |
|
WisdomTree Inc
F:1WT
|
US |
|
Fiore Cannabis Ltd
OTC:FIORF
|
CA |
|
C
|
China International Capital Corp Ltd
SWB:CIM
|
CN |
|
R
|
Radiant Cash Management Services Ltd
NSE:RADIANTCMS
|
IN |
|
Carlo Gavazzi Holding AG
F:D9N0
|
CH |
|
W
|
Woori Technology Investment Co Ltd
KOSDAQ:041190
|
KR |
|
H
|
Helmerich and Payne Inc
F:HPC
|
US |
Evoke PLC (C8V)’s 12-month stock price forecast through November 2027 has a consensus target of €0.545, implying 1% downside. The forecast is based on price targets from 5 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
C8V is 0.545 EUR with a low forecast of 0.539 EUR and a high forecast of 0.561 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 3%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 3 years is -1%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 13%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more